Insider trading is the trading of a company’s securities by individuals with access to confidential or material non-public information about the company.
A company is required to report trading by corporate officers, directors, or other company members with significant access to privileged information to the Securities and Exchange Commission (SEC).
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Local Bounti Corp (Class A) | Kathleen Valiasek | President and CEO | Sale of securities on an exchange or to another person at price $ 1.30 per share. | 02 Jul 2026 | 118,720 | 1,524,860 | - | 1.3 | 154,336 | Common Stock |
| ePlus Inc | Mark P. Marron | Director, CHIEF EXECUTIVE OFFICER | Other type of transaction at price $ 0.00 per share. | 02 Jul 2026 | 25,562 | 169,360 (1%) | 0% | 0 | Common Stock | |
| ePlus Inc | Mark P. Marron | Director, CHIEF EXECUTIVE OFFICER | Other type of transaction at price $ 0.00 per share. | 02 Jul 2026 | 25,562 | 56,713 (0%) | 0% | 0 | Common Stock | |
| Regional Management Corp | Harpreet Rana | EVP, Chief Fin & Admin Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jul 2026 | 17,466 | 63,635 (0%) | 0% | 0 | Common Stock | |
| ePlus Inc | Elaine D. Marion | CHIEF FINANCIAL OFFICER | Other type of transaction at price $ 0.00 per share. | 02 Jul 2026 | 15,214 | 34,801 (0%) | 0% | 0 | Common Stock | |
| ePlus Inc | Elaine D. Marion | CHIEF FINANCIAL OFFICER | Other type of transaction at price $ 0.00 per share. | 02 Jul 2026 | 15,214 | 93,835 (0%) | 0% | 0 | Common Stock | |
| Regional Management Corp | Brian J. Fisher | EVP, Chief Strat/Dev Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jul 2026 | 13,247 | 46,117 (0%) | 0% | 0 | Common Stock | |
| Aeva Tech Inc | Saurabh Sinha | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 26.75 per share. | 02 Jul 2026 | 11,212 | 678,822 | - | 26.8 | 299,974 | Common Stock |
| Nurix Therapeutics Inc | Christine Ring | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 23.56 per share. | 02 Jul 2026 | 11,008 | 13,579 | - | 23.6 | 259,366 | Common Stock |
| Regional Management Corp | Manish Parmar | EVP, Chief Credit Risk Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jul 2026 | 10,695 | 71,847 (0%) | 0% | 0 | Common Stock | |
| United Therapeutics Corp | Martine A. Rothblatt | Director, Chairperson & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 135.42 per share. | 02 Jul 2026 | 9,500 | 50,013 (0%) | 0% | 135.4 | 1,286,490 | Common Stock |
| United Therapeutics Corp | Martine A. Rothblatt | Director, Chairperson & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Jul 2026 | 9,500 | 68,218 | - | - | Stock Option | |
| Regional Management Corp | Catherine R. Atwood | SVP and General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jul 2026 | 8,321 | 55,707 (0%) | 0% | 0 | Common Stock | |
| United Therapeutics Corp | Paul A. Mahon | EVP & GENERAL COUNSEL | Exercise or conversion of derivative security received from the company (such as an option) at price $ 146.03 per share. | 02 Jul 2026 | 8,300 | 53,472 (0%) | 0% | 146.0 | 1,212,049 | Common Stock |
| United Therapeutics Corp | Paul A. Mahon | EVP & GENERAL COUNSEL | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Jul 2026 | 8,300 | 89,040 | - | - | Stock Option | |
| BP PLC (ADR) | Katherine Anne Thomson | Executive Director,Chief Financial Officer | Sale or transfer of securities back to the company at price $ 4.58 per share. | 02 Jul 2026 | 7,107 | 1,314,813 (0%) | 0% | 4.6 | 32,567 | Ords 0.25p |
| Weyco Grp Inc | Brian Flannery | VP, PRESIDENT - STACY ADAMS | Exercise or conversion of derivative security received from the company (such as an option) at price $ 18.00 per share. | 02 Jul 2026 | 6,000 | 41,760 (0%) | 0% | 18 | 108,000 | Common Stock |
| Nurix Therapeutics Inc | Christine Ring | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Jul 2026 | 5,787 | 128,611 | - | - | Employee Stock Option (right to buy) | |
| Nurix Therapeutics Inc | Christine Ring | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 8.72 per share. | 02 Jul 2026 | 5,787 | 24,587 | - | 8.7 | 50,463 | Common Stock |
| Nurix Therapeutics Inc | Christine Ring | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Jul 2026 | 5,221 | 0 | - | - | Employee Stock Option (right to buy) | |
| Nurix Therapeutics Inc | Christine Ring | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.86 per share. | 02 Jul 2026 | 5,221 | 18,800 | - | 1.9 | 9,711 | Common Stock |
| Weyco Grp Inc | Brian Flannery | VP, PRESIDENT - STACY ADAMS | Payment of exercise price or tax liability using portion of securities received from the company at price $ 39.89 per share. | 02 Jul 2026 | 3,567 | 39,393 (0%) | 0% | 39.9 | 142,288 | Common Stock |
| Edesa Biotech Inc | Pardeep Nijhawan | Director, Chief Executive Officer, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jul 2026 | 3,378 | 888,062 (10%) | 0% | 0 | Common Shares | |
| Hilton Grand Vacations Inc | Christine Marie Duffy | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jul 2026 | 3,190 | 3,190 (0%) | 0% | 0 | Common Stock | |
| United Therapeutics Corp | Martine A. Rothblatt | Director, Chairperson & CEO | Sale of securities on an exchange or to another person at price $ 555.67 per share. | 02 Jul 2026 | 2,942 | 42,216 (0%) | 0% | 555.7 | 1,634,790 | Common Stock |
| RingCentral Inc (Class A) | Robert Theis | Director | Sale of securities on an exchange or to another person at price $ 40.28 per share. | 02 Jul 2026 | 2,530 | 30,834 (0%) | 0% | 40.3 | 101,908 | Class A Common Stock |
| MGP Ingredients Inc | Martin F. Roper | Director | Grant, award, or other acquisition of securities at price $ 17.36 per share. | 02 Jul 2026 | 2,232 | 35,503 (0%) | 0% | 17.4 | 38,748 | Common Stock |
| United Therapeutics Corp | Paul A. Mahon | EVP & GENERAL COUNSEL | Sale of securities on an exchange or to another person at price $ 553.52 per share. | 02 Jul 2026 | 2,201 | 46,686 (0%) | 0% | 553.5 | 1,218,290 | Common Stock |
| United Therapeutics Corp | Martine A. Rothblatt | Director, Chairperson & CEO | Sale of securities on an exchange or to another person at price $ 554.75 per share. | 02 Jul 2026 | 2,006 | 45,158 (0%) | 0% | 554.8 | 1,112,830 | Common Stock |
| United Therapeutics Corp | Paul A. Mahon | EVP & GENERAL COUNSEL | Sale of securities on an exchange or to another person at price $ 552.61 per share. | 02 Jul 2026 | 1,818 | 48,887 (0%) | 0% | 552.6 | 1,004,639 | Common Stock |
| Black Stone Minerals L.P. - Unit | Alexander D. Stuart | Director | Grant, award, or other acquisition of securities at price $ 13.97 per share. | 02 Jul 2026 | 1,700 | 2,055,975 (0%) | 0% | 14.0 | 23,749 | Common units representing limited partner interests |
| Black Stone Minerals L.P. - Unit | William E. Randall | Director | Grant, award, or other acquisition of securities at price $ 13.97 per share. | 02 Jul 2026 | 1,610 | 193,384 (0%) | 0% | 14.0 | 22,492 | Common units representing limited partner interests |
| United Therapeutics Corp | Paul A. Mahon | EVP & GENERAL COUNSEL | Sale of securities on an exchange or to another person at price $ 551.30 per share. | 02 Jul 2026 | 1,467 | 50,705 (0%) | 0% | 551.3 | 808,751 | Common Stock |
| United Therapeutics Corp | Martine A. Rothblatt | Director, Chairperson & CEO | Sale of securities on an exchange or to another person at price $ 556.56 per share. | 02 Jul 2026 | 1,343 | 40,873 (0%) | 0% | 556.6 | 747,461 | Common Stock |
| Black Stone Minerals L.P. - Unit | D. Mark DeWalch | Director | Grant, award, or other acquisition of securities at price $ 13.97 per share. | 02 Jul 2026 | 1,342 | 432,837 (0%) | 0% | 14.0 | 18,748 | Common units representing limited partner interests |
| Black Stone Minerals L.P. - Unit | Jerry V. Kyle | Director | Grant, award, or other acquisition of securities at price $ 13.97 per share. | 02 Jul 2026 | 1,342 | 322,489 (0%) | 0% | 14.0 | 18,748 | Common units representing limited partner interests |
| Black Stone Minerals L.P. - Unit | Anne Lenoir Hamman | Director | Grant, award, or other acquisition of securities at price $ 13.97 per share. | 02 Jul 2026 | 1,342 | 8,428 (0%) | 0% | 14.0 | 18,748 | Common units representing limited partner interests |
| RingCentral Inc (Class A) | Amy Guggenheim Shenkan | Director | Sale of securities on an exchange or to another person at price $ 40.59 per share. | 02 Jul 2026 | 1,265 | 29,372 (0%) | 0% | 40.6 | 51,350 | Class A Common Stock |
| Grid Dynamics Holdings Inc (Class A) | Yury Gryzlov | CHIEF OPERATING OFFICER | Sale of securities on an exchange or to another person at price $ 6.29 per share. | 02 Jul 2026 | 1,245 | 512,017 | - | 6.3 | 7,831 | Common Stock |
| Weyco Grp Inc | Brian Flannery | VP, PRESIDENT - STACY ADAMS | Exercise or conversion of derivative security received from the company (such as an option) at price $ 24.00 per share. | 02 Jul 2026 | 1,200 | 42,960 (0%) | 0% | 24 | 28,800 | Common Stock |
| United Therapeutics Corp | Martine A. Rothblatt | Director, Chairperson & CEO | Sale of securities on an exchange or to another person at price $ 552.73 per share. | 02 Jul 2026 | 993 | 47,940 (0%) | 0% | 552.7 | 548,856 | Common Stock |
| United Therapeutics Corp | Paul A. Mahon | EVP & GENERAL COUNSEL | Sale of securities on an exchange or to another person at price $ 555.83 per share. | 02 Jul 2026 | 990 | 45,397 (0%) | 0% | 555.8 | 550,267 | Common Stock |
| United Therapeutics Corp | Martine A. Rothblatt | Director, Chairperson & CEO | Sale of securities on an exchange or to another person at price $ 553.64 per share. | 02 Jul 2026 | 776 | 47,164 (0%) | 0% | 553.6 | 429,623 | Common Stock |
| Alarm.com Holdings Inc | Kevin Bradley | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 48.46 per share. | 02 Jul 2026 | 724 | 83,622 (0%) | 0% | 48.5 | 35,085 | Common Stock |
| United Therapeutics Corp | Paul A. Mahon | EVP & GENERAL COUNSEL | Sale of securities on an exchange or to another person at price $ 548.00 per share. | 02 Jul 2026 | 658 | 52,814 (0%) | 0% | 548.0 | 360,585 | Common Stock |
| United Therapeutics Corp | Martine A. Rothblatt | Director, Chairperson & CEO | Sale of securities on an exchange or to another person at price $ 551.59 per share. | 02 Jul 2026 | 640 | 48,933 (0%) | 0% | 551.6 | 353,019 | Common Stock |
| Gibraltar Ind Inc | Manish H. Shah | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jul 2026 | 483 | 7,649 | - | - | Restricted Stock Unit (MSPP Post-2012) | |
| United Therapeutics Corp | Paul A. Mahon | EVP & GENERAL COUNSEL | Sale of securities on an exchange or to another person at price $ 550.02 per share. | 02 Jul 2026 | 384 | 52,172 (0%) | 0% | 550.0 | 211,209 | Common Stock |
| United Therapeutics Corp | Martine A. Rothblatt | Director, Chairperson & CEO | Sale of securities on an exchange or to another person at price $ 557.62 per share. | 02 Jul 2026 | 320 | 40,553 (0%) | 0% | 557.6 | 178,440 | Common Stock |
| United Therapeutics Corp | Paul A. Mahon | EVP & GENERAL COUNSEL | Sale of securities on an exchange or to another person at price $ 554.44 per share. | 02 Jul 2026 | 299 | 46,387 (0%) | 0% | 554.4 | 165,779 | Common Stock |
| United Therapeutics Corp | Paul A. Mahon | EVP & GENERAL COUNSEL | Sale of securities on an exchange or to another person at price $ 548.73 per share. | 02 Jul 2026 | 258 | 52,556 (0%) | 0% | 548.7 | 141,573 | Common Stock |
| United Therapeutics Corp | Paul A. Mahon | EVP & GENERAL COUNSEL | Sale of securities on an exchange or to another person at price $ 556.36 per share. | 02 Jul 2026 | 225 | 45,172 (0%) | 0% | 556.4 | 125,181 | Common Stock |
| United Therapeutics Corp | Martine A. Rothblatt | Director, Chairperson & CEO | Sale of securities on an exchange or to another person at price $ 548.01 per share. | 02 Jul 2026 | 192 | 49,821 (0%) | 0% | 548.0 | 105,217 | Common Stock |
| United Therapeutics Corp | Martine A. Rothblatt | Director, Chairperson & CEO | Sale of securities on an exchange or to another person at price $ 548.75 per share. | 02 Jul 2026 | 130 | 49,691 (0%) | 0% | 548.8 | 71,338 | Common Stock |
| United Therapeutics Corp | Martine A. Rothblatt | Director, Chairperson & CEO | Sale of securities on an exchange or to another person at price $ 549.76 per share. | 02 Jul 2026 | 118 | 49,573 (0%) | 0% | 549.8 | 64,872 | Common Stock |
| ON Semiconductor | Paul A. Mascarenas | Director | Grant, award, or other acquisition of securities at price $ 91.22 per share. | 02 Jul 2026 | 116 | 57,590 (0%) | 0% | 91.2 | 10,582 | Common |
| BP PLC (ADR) | Carol Howle | Executive Director,Chief Executive Officer (Interim) | Sale or transfer of securities back to the company at price $ 4.70 per share. | 02 Jul 2026 | 109 | 1,105,707 (0%) | 0% | 4.7 | 512 | Ords 0.25p |
| BP PLC (ADR) | Katherine Anne Thomson | Executive Director,Chief Financial Officer | Sale or transfer of securities back to the company at price $ 4.69 per share. | 02 Jul 2026 | 74 | 1,314,887 (0%) | 0% | 4.7 | 347 | Ords 0.25p |
| Auburn National Bancorp Inc | J. Tutt Barrett | Director | Purchase of securities on an exchange or from another person at price $ 26.90 per share. | 02 Jul 2026 | 51 | 9,250 (0%) | 0% | 26.9 | 1,372 | common stock, par value $0.1 |
| Auburn National Bancorp Inc | William F. Ham | Director | Purchase of securities on an exchange or from another person at price $ 26.89 per share. | 02 Jul 2026 | 47 | 5,084 (0%) | 0% | 26.9 | 1,264 | common stock, par value $0.1 |
| United Therapeutics Corp | Martine A. Rothblatt | Director, Chairperson & CEO | Sale of securities on an exchange or to another person at price $ 558.38 per share. | 02 Jul 2026 | 40 | 40,513 (0%) | 0% | 558.4 | 22,335 | Common Stock |
| Auburn National Bancorp Inc | David E. Housel | Director | Purchase of securities on an exchange or from another person at price $ 26.89 per share. | 02 Jul 2026 | 37 | 9,301 (0%) | 0% | 26.9 | 995 | common stock, par value $0.1 |
| Auburn National Bancorp Inc | J. Tutt Barrett | Director | Purchase of securities on an exchange or from another person at price $ 26.00 per share. | 02 Jul 2026 | 23 | 9,273 (0%) | 0% | 26 | 598 | common stock, par value $0.1 |
| Auburn National Bancorp Inc | David E. Housel | Director | Purchase of securities on an exchange or from another person at price $ 26.00 per share. | 02 Jul 2026 | 16 | 9,317 (0%) | 0% | 26 | 416 | common stock, par value $0.1 |
| Auburn National Bancorp Inc | William F. Ham | Director | Purchase of securities on an exchange or from another person at price $ 26.00 per share. | 02 Jul 2026 | 10 | 5,094 (0%) | 0% | 26 | 260 | common stock |
| Iris Energy Ltd | Daniel Roberts | Director, Co-Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2026 | 9,099,328 | 23,089,024 | - | 0 | Ordinary Shares | |
| Iris Energy Ltd | William Roberts | Director, Co-Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2026 | 9,099,328 | 23,089,024 | - | 0 | Ordinary Shares | |
| Kodiak AI Inc | Surajit Datta | Chief Financial Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 01 Jul 2026 | 2,035,915 | 0 | - | - | Stock Option (Right to buy) | |
| Kodiak AI Inc | Donald L. Burnette | Director, Chief Executive Officer, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2026 | 1,168,614 | 27,083,818 | - | 0 | Common Stock | |
| Leap Therapeutics Inc | Douglas E. Onsi | Director, CEO,CFO,Pres.,GC,Treas.&Sec. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2026 | 1,000,000 | 1,000,000 | - | - | Restricted Stock Units | |
| Leap Therapeutics Inc | William McEvoy | Director, Chief Investment Officer, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2026 | 1,000,000 | 1,000,000 | - | - | Restricted Stock Units | |
| ARS Pharma Inc | Donn Casale | President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2026 | 898,456 | 898,456 | - | - | Stock Option (right to buy) | |
| Fortune Brands Innovations Inc | Jesse G. Singh | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2026 | 850,000 | 850,000 | - | - | Performance Stock Units | |
| Kodiak AI Inc | Surajit Datta | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2026 | 563,063 | 563,063 | - | 0 | Common Stock | |
| Patriot National Bancorp Inc | Steven A. Sugarman | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jul 2026 | 552,927 | 1,252,058 | - | - | Restricted Stock Units | |
| Patriot National Bancorp Inc | Steven A. Sugarman | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jul 2026 | 552,927 | 2,641,970 (67%) | 14% | 0 | Voting Common Stock | |
| Iris Energy Ltd | Daniel Roberts | Director, Co-Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2026 | 552,197 | 23,641,221 | - | 0 | Ordinary Shares | |
| Iris Energy Ltd | William Roberts | Director, Co-Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2026 | 552,197 | 23,641,221 | - | 0 | Ordinary Shares | |
| Kodiak AI Inc | Andreas Wendel | Chief Technology Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2026 | 434,056 | 4,739,629 | - | 0 | Common Stock | |
| Kodiak AI Inc | Michael Wiesinger | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2026 | 417,362 | 596,102 | - | 0 | Common Stock | |
| Kodiak AI Inc | Surajit Datta | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2026 | 417,362 | 980,425 | - | 0 | Common Stock | |
| Applied Digital Corp | Jason Zhang | President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2026 | 375,000 | 2,372,078 | - | - | Common Stock | |
| Lixte biotech Holdings Inc | Geordan Pursglove | Director, CEO and Chairman of the Board | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2026 | 350,000 | 700,000 | - | 0 | Common Stock | |
| Clover Health Investments Corp (Class A) | Andrew Toy | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 5.32 per share. | 01 Jul 2026 | 313,476 | 9,609,825 | - | 5.3 | 1,667,692 | Class A Common Stock |
| Patriot National Bancorp Inc | Steven A. Sugarman | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.20 per share. | 01 Jul 2026 | 303,861 | 2,338,109 (59%) | 7% | 1.2 | 364,633 | Voting Common Stock |
| Applied Digital Corp | Jason Zhang | President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2026 | 300,000 | 2,115,128 | - | - | Common Stock | |
| Phibro Animal Health Corp (Class A) | Daniel M. Bendheim | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2026 | 300,000 | 300,000 | - | - | Performance Stock Units | |
| Fortune Brands Innovations Inc | Jesse G. Singh | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2026 | 300,000 | 300,000 | - | - | Options (Right to Buy) | |
| Kodiak AI Inc | Jordan S. Coleman | Chief Legal and Policy Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2026 | 292,153 | 296,624 | - | 0 | Common Stock | |
| KORU Medical Systems Inc | Adam R. Kalbermatten | President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2026 | 286,697 | 286,697 | - | - | Performance Stock Unit | |
| Warby Parker Inc (Class A) | David Gilboa | Director, Co-Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 29.69 per share. | 01 Jul 2026 | 242,221 | 31,112 | - | 29.7 | 7,191,541 | Class A Common Stock |
| National Grid PLC (ADR) | Andrew Agg | Executive Director,Chief Financial Officer | 01 Jul 2026 | 220,905 | 1,126,065 (0%) | 0% | 0 | - | ||
| Warby Parker Inc (Class A) | Neil Blumenthal | Director, Co-Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 29.61 per share. | 01 Jul 2026 | 217,667 | 31,112 | - | 29.6 | 6,445,120 | Class A Common Stock |
| Warby Parker Inc (Class A) | David Gilboa | Director, Co-Chief Executive Officer | 01 Jul 2026 | 213,746 | 273,333 | - | 0 | Class A Common Stock | ||
| Warby Parker Inc (Class A) | David Gilboa | Director, Co-Chief Executive Officer | 01 Jul 2026 | 213,746 | 4,555,404 | - | - | Class B Common Stock | ||
| Kodiak AI Inc | Zsuzsanna Major | Chief People Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2026 | 200,333 | 210,333 | - | 0 | Common Stock | |
| Warby Parker Inc (Class A) | Neil Blumenthal | Director, Co-Chief Executive Officer | 01 Jul 2026 | 189,320 | 248,779 | - | 0 | Class A Common Stock | ||
| Warby Parker Inc (Class A) | Neil Blumenthal | Director, Co-Chief Executive Officer | 01 Jul 2026 | 189,320 | 3,229,650 | - | - | Class B Common Stock | ||
| QXO Inc | Alec C. Covington | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2026 | 150,368 | 150,368 (3%) | 3% | - | Common Stock, $0.00001 par value | |
| Applied Digital Corp | Jason Zhang | President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 35.52 per share. | 01 Jul 2026 | 147,563 | 2,224,515 | - | 35.5 | 5,241,438 | Common Stock |
| Oramed Pharma Inc | Joshua Hexter | COO & CBO | Sale of securities on an exchange or to another person at price $ 4.46 per share. | 01 Jul 2026 | 137,000 | 1,023,384 (5%) | 0% | 4.5 | 611,431 | Common Stock |
| Edgewise Therapeutics Inc | Alan Russell | Director, Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jul 2026 | 130,352 | 0 | - | - | Stock Option (Right to Buy) | |
| Edgewise Therapeutics Inc | Alan Russell | Director, Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 39.41 per share. | 01 Jul 2026 | 130,352 | 94,203 | - | 39.4 | 5,136,651 | Common Stock |
| Edgewise Therapeutics Inc | Alan Russell | Director, Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.45 per share. | 01 Jul 2026 | 130,352 | 154,907 | - | 0.4 | 58,658 | Common Stock |
| Halozyme Therapeutics Inc | Darren Snellgrove | SVP, Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2026 | 127,432 | 127,432 | - | - | Option to Purchase Common Stock | |
| Mondelez (Class A) | Amit Banati | EVP and CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2026 | 122,210 | 122,210 | - | - | Stock Options (right to buy) | |
| Applied Digital Corp | Jason Zhang | President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 35.52 per share. | 01 Jul 2026 | 118,050 | 1,997,078 | - | 35.5 | 4,193,136 | Common Stock |
| Warby Parker Inc (Class A) | David Gilboa | Director, Co-Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jul 2026 | 117,221 | 593,538 | - | - | Stock Option (Right to Buy) | |
| Warby Parker Inc (Class A) | David Gilboa | Director, Co-Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jul 2026 | 117,221 | 4,769,150 | - | - | Class B Common Stock | |
| X4 Pharma Inc | Kelly Gold | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2026 | 110,000 | 110,000 | - | - | Stock Option (right to buy) | |
| National Grid PLC (ADR) | Andrew Agg | Executive Director,Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 12.21 per share. | 01 Jul 2026 | 104,191 | 1,021,874 (0%) | 0% | 12.2 | 1,272,195 | - |
| Leap Therapeutics Inc | Thomas J. Dietz | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2026 | 100,000 | 100,000 | - | - | Restricted Stock Units | |
| Leap Therapeutics Inc | Khing Djien Oei | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2026 | 100,000 | 100,000 | - | - | Restricted Stock Units | |
| MediaAlpha Inc (Class A) | Steven M. Yi | Director, See Remarks | Sale of securities on an exchange or to another person at price $ 12.90 per share. | 01 Jul 2026 | 96,000 | 2,759,690 | - | 12.9 | 1,238,669 | Class A Common Stock |
| Xeris Biopharma Holdings Inc | Kevin McCulloch | See Remarks | Sale of securities on an exchange or to another person at price $ 8.03 per share. | 01 Jul 2026 | 90,000 | 1,691,126 (6%) | 0% | 8.0 | 722,511 | Common Stock |
| Alignment Healthcare Inc | Shane J. Hochradel | Chief Operations Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2026 | 87,719 | 87,719 | - | 0 | Common Stock | |
| Hinge Health Inc (Class A) | Gabriel Mecklenburg | Director, Exec. Chairman & Co-Founder | 01 Jul 2026 | 83,334 | 1,644,007 | - | - | Class B Common Stock | ||
| Hinge Health Inc (Class A) | Gabriel Mecklenburg | Director, Exec. Chairman & Co-Founder | 01 Jul 2026 | 83,334 | 83,334 | - | 0 | Class A Common Stock | ||
| Kymera Therapeutics Inc | Nello Mainolfi | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.08 per share. | 01 Jul 2026 | 80,000 | 746,568 | - | 2.1 | 166,400 | Common Stock |
| Kymera Therapeutics Inc | Nello Mainolfi | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jul 2026 | 80,000 | 135,559 | - | - | Stock Option (Right to Buy) | |
| Leap Therapeutics Inc | Nissim Mashiach | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2026 | 75,000 | 75,000 | - | - | Restricted Stock Units | |
| Leap Therapeutics Inc | William W. Li | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2026 | 75,000 | 75,000 | - | - | Restricted Stock Units | |
| Leap Therapeutics Inc | Patricia Martin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2026 | 75,000 | 75,000 | - | - | Restricted Stock Units | |
| Leap Therapeutics Inc | Christian Richard | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2026 | 75,000 | 75,000 | - | - | Restricted Stock Units | |
| Oramed Pharma Inc | Avraham Gabay | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 4.51 per share. | 01 Jul 2026 | 73,360 | 671,785 (3%) | 0% | 4.5 | 330,744 | Common Stock |
| Baker Hughes | Maria Claudia Borras | Chief Growth & Experience Ofcr | Sale of securities on an exchange or to another person at price $ 55.05 per share. | 01 Jul 2026 | 72,000 | 20,035 (0%) | 0% | 55.1 | 3,963,600 | Class A Common Stock |
| Edgewise Therapeutics Inc | Alan Russell | Director, Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jul 2026 | 69,648 | 1,077,717 | - | - | Stock Option (Right to Buy) | |
| Edgewise Therapeutics Inc | Alan Russell | Director, Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 39.41 per share. | 01 Jul 2026 | 69,648 | 24,555 | - | 39.4 | 2,744,751 | Common Stock |
| Edgewise Therapeutics Inc | Alan Russell | Director, Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.18 per share. | 01 Jul 2026 | 69,648 | 224,555 | - | 0.2 | 12,537 | Common Stock |
| BorgWarner Inc | Tonit M. Calaway | EVP, CAO, Gen Counsel & Sec | Payment of exercise price or tax liability using portion of securities received from the company at price $ 66.40 per share. | 01 Jul 2026 | 68,854 | 139,652 (0%) | 0% | 66.4 | 4,571,906 | Common Stock |
| Arteris Inc | K. Charles Janac | Director, President and CEO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 44.06 per share. | 01 Jul 2026 | 63,562 | 8,837,818 | - | 44.1 | 2,800,580 | Common Stock |
| Marathon Digital Holdings Inc | Frederick G. Thiel | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 13.89 per share. | 01 Jul 2026 | 63,101 | 4,498,908 (57%) | 0% | 13.9 | 876,473 | Common Stock |
| Marathon Digital Holdings Inc | Salman H. Khan | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 13.89 per share. | 01 Jul 2026 | 61,515 | 1,670,140 (21%) | 0% | 13.9 | 854,443 | Common Stock |
| Oklo Inc (Class A) | Jacob DeWitte | Director, Co-Founder, CEO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 52.80 per share. | 01 Jul 2026 | 60,000 | 511,533 | - | 52.8 | 3,168,000 | Class A Common Stock |
| Oklo Inc (Class A) | Jacob DeWitte | Director, Co-Founder, CEO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 52.30 per share. | 01 Jul 2026 | 60,000 | 478,039 | - | 52.3 | 3,138,000 | Class A Common Stock |
| Oklo Inc (Class A) | Caroline DeWitte | Director, Co-Founder, COO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 52.30 per share. | 01 Jul 2026 | 60,000 | 478,039 | - | 52.3 | 3,138,000 | Class A Common Stock |
| Oklo Inc (Class A) | Caroline DeWitte | Director, Co-Founder, COO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 52.80 per share. | 01 Jul 2026 | 60,000 | 511,533 | - | 52.8 | 3,168,000 | Class A Common Stock |
| SentinelOne Inc (Class A) | Tomer Weingarten | Director, President, CEO | 01 Jul 2026 | 57,941 | 1,952,338 | - | 0 | Class A Common Stock | ||
| SentinelOne Inc (Class A) | Tomer Weingarten | Director, President, CEO | 01 Jul 2026 | 57,941 | 3,537,035 | - | - | Class B Common Stock | ||
| SentinelOne Inc (Class A) | Tomer Weingarten | Director, President, CEO | Sale of securities on an exchange or to another person at price $ 17.71 per share. | 01 Jul 2026 | 57,941 | 1,894,397 | - | 17.7 | 1,025,851 | Class A Common Stock |
| Hinge Health Inc (Class A) | Gabriel Mecklenburg | Director, Exec. Chairman & Co-Founder | Sale of securities on an exchange or to another person at price $ 85.00 per share. | 01 Jul 2026 | 56,518 | 19,416 | - | 85.0 | 4,804,205 | Class A Common Stock |
| Rush Street Interactive Inc (Class A) | Richard Schwartz | Director, Chief Executive Officer | 01 Jul 2026 | 55,556 | 55,556 | - | 0 | Class A Common Stock | ||
| Rush Street Interactive Inc (Class A) | Richard Schwartz | Director, Chief Executive Officer | 01 Jul 2026 | 55,556 | 537,540 | - | - | Class A Common Units of Rush Street Interactive, L.P. | ||
| Rush Street Interactive Inc (Class A) | Richard Schwartz | Director, Chief Executive Officer | 01 Jul 2026 | 55,556 | 537,540 | - | - | Class A Common Units of Rush Street Interactive, L.P. | ||
| Rush Street Interactive Inc (Class A) | Richard Schwartz | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 31.21 per share. | 01 Jul 2026 | 55,556 | 0 | - | 31.2 | 1,734,169 | Class A Common Stock |
| Rush Street Interactive Inc (Class A) | Richard Schwartz | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 31.21 per share. | 01 Jul 2026 | 55,556 | 0 | - | 31.2 | 1,734,169 | Class A Common Stock |
| Rush Street Interactive Inc (Class A) | Richard Schwartz | Director, Chief Executive Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 01 Jul 2026 | 55,556 | 537,540 | - | 0 | Class V Voting Stock | |
| Rush Street Interactive Inc (Class A) | Richard Schwartz | Director, Chief Executive Officer | 01 Jul 2026 | 55,556 | 55,556 | - | 0 | Class A Common Stock | ||
| Rush Street Interactive Inc (Class A) | Richard Schwartz | Director, Chief Executive Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 01 Jul 2026 | 55,556 | 537,540 | - | 0 | Class V Voting Stock | |
| JFrog Ltd | Frederic Simon | Director | Sale of securities on an exchange or to another person at price $ 90.91 per share. | 01 Jul 2026 | 54,774 | 3,140,779 | - | 90.9 | 4,979,504 | Ordinary Shares |
| Amplify Energy Corp | Christopher W. Hamm | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jul 2026 | 51,043 | 323,121 (0%) | 0% | - | Common Stock, par value $0.01 per share | |
| Amplify Energy Corp | Christopher W. Hamm | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jul 2026 | 51,043 | 0 | - | - | Restricted Stock Units | |
| e.l.f. Beauty Inc | Tarang P. Amin | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jul 2026 | 50,164 | 91,836 | - | - | Stock Option (Right to Buy) | |
| e.l.f. Beauty Inc | Tarang P. Amin | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 26.84 per share. | 01 Jul 2026 | 50,164 | 160,660 (0%) | 0% | 26.8 | 1,346,402 | Common Stock, $0.01 par value |
| Journey Medical Corp | Neil Herskowitz | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2026 | 50,000 | 168,618 | - | 0 | Common Stock, $0.0001 par value | |
| Journey Medical Corp | Miranda Jayne Toledano | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2026 | 50,000 | 168,618 | - | 0 | Common Stock, $0.0001 par value | |
| Journey Medical Corp | Justin Smith | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2026 | 50,000 | 231,618 | - | 0 | Common Stock, $0.0001 par value | |
| Lixte biotech Holdings Inc | Peter Stazzone | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2026 | 50,000 | 100,000 | - | 0 | Common Stock | |
| Sunrun Inc | Lynn Jurich | Director | Sale of securities on an exchange or to another person at price $ 13.61 per share. | 01 Jul 2026 | 50,000 | 409,091 (0%) | 0% | 13.6 | 680,320 | Common Stock |
| Circle Internet Grp Inc (Class A) | P. Sean Neville | Director | 01 Jul 2026 | 50,000 | 3,115,909 | - | - | Class B Common Stock | ||
| Circle Internet Grp Inc (Class A) | P. Sean Neville | Director | 01 Jul 2026 | 50,000 | 52,018 | - | - | Class A Common Stock | ||
| Carvana Co. (Class A) | Mark Jenkins | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.01 per share. | 01 Jul 2026 | 50,000 | 1,079,580 (2%) | 0% | 2.0 | 100,500 | Class A Common Stock |
| Carvana Co. (Class A) | Mark Jenkins | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jul 2026 | 50,000 | 542,565 | - | - | Stock Options (Right to Buy) | |
| Extreme Networks Inc | Edward B. Meyercord | Director, PRESIDENT AND CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jul 2026 | 50,000 | 24,573 | - | - | Non-Qualified Stock Option (right to buy) | |
| Extreme Networks Inc | Edward B. Meyercord | Director, PRESIDENT AND CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.70 per share. | 01 Jul 2026 | 50,000 | 1,671,902 (1%) | 0% | 6.7 | 335,000 | Common Stock |
| Extreme Networks Inc | Edward B. Meyercord | Director, PRESIDENT AND CEO | Sale of securities on an exchange or to another person at price $ 31.71 per share. | 01 Jul 2026 | 50,000 | 1,621,902 (1%) | 0% | 31.7 | 1,585,500 | Common Stock |
| Happen Inc | Fergal Stack | SVP, Corporate Controller | Sale of securities on an exchange or to another person at price $ 21.01 per share. | 01 Jul 2026 | 50,000 | 154,977 (0%) | 0% | 21.0 | 1,050,690 | Common Stock |
| Oramed Pharma Inc | Joshua Hexter | COO & CBO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jul 2026 | 50,000 | 50,000 | - | - | Stock option (right to buy) | |
| Oramed Pharma Inc | Joshua Hexter | COO & CBO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.69 per share. | 01 Jul 2026 | 50,000 | 1,073,384 (6%) | 0% | 3.7 | 184,500 | Common Stock |
| Tetra Technologies Inc | Brady M. Murphy | President & CEO | Sale of securities on an exchange or to another person at price $ 10.72 per share. | 01 Jul 2026 | 50,000 | 2,965,457 (2%) | 0% | 10.7 | 536,135 | Common Stock |
| Arteris Inc | K. Charles Janac | Director, President and CEO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 46.17 per share. | 01 Jul 2026 | 49,680 | 8,788,138 | - | 46.2 | 2,293,492 | Common Stock |
| Axsome Therapeutics Inc | Herriot Tabuteau | Director, Chief Executive Officer, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jul 2026 | 49,666 | 49,664 | - | - | Stock Option (Right to Buy) | |
| Axsome Therapeutics Inc | Herriot Tabuteau | Director, Chief Executive Officer, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 240.25 per share. | 01 Jul 2026 | 49,666 | 7,229 (0%) | 0% | 240.3 | 11,932,257 | Common Stock |
| Axsome Therapeutics Inc | Herriot Tabuteau | Director, Chief Executive Officer, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.95 per share. | 01 Jul 2026 | 49,666 | 56,895 (0%) | 0% | 5.0 | 245,847 | Common Stock |
| MoonLake Immunotherapeutics (Class A) | Jorge Santos da Silva | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 20.03 per share. | 01 Jul 2026 | 47,775 | 2,877,118 | - | 20.0 | 956,933 | Class A ordinary shares, par value $0.0001 per share |
| Rush Street Interactive Inc (Class A) | Richard Schwartz | Director, Chief Executive Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 01 Jul 2026 | 47,222 | 5,184,441 | - | 0 | Class V Voting Stock | |
| Rush Street Interactive Inc (Class A) | Richard Schwartz | Director, Chief Executive Officer | 01 Jul 2026 | 47,222 | 421,258 | - | 0 | Class A Common Stock | ||
| Rush Street Interactive Inc (Class A) | Richard Schwartz | Director, Chief Executive Officer | 01 Jul 2026 | 47,222 | 5,184,441 | - | - | Class A Common Units of Rush Street Interactive, L.P. | ||
| Rush Street Interactive Inc (Class A) | Richard Schwartz | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 31.21 per share. | 01 Jul 2026 | 47,222 | 374,036 | - | 31.2 | 1,474,025 | Class A Common Stock |
| Kymera Therapeutics Inc | Nello Mainolfi | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 115.69 per share. | 01 Jul 2026 | 44,050 | 669,904 | - | 115.7 | 5,096,070 | Common Stock |
| Amplify Energy Corp | Christopher W. Hamm | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2026 | 43,911 | 43,911 | - | - | Restricted Stock Units | |
| Barrett Business Services Inc | Gary E. Kramer | President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2026 | 43,367 | 43,367 | - | - | Restricted Stock Units | |
| Amplify Energy Corp | Clint Coghill | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jul 2026 | 41,922 | 0 | - | - | Restricted Stock Units | |
| Amplify Energy Corp | Clint Coghill | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jul 2026 | 41,922 | 44,332 (0%) | 0% | - | Common Stock, par value $0.01 per share | |
| Halozyme Therapeutics Inc | Darren Snellgrove | SVP, Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2026 | 41,554 | 41,554 | - | - | Restricted Stock Units | |
| FTAI Aviation Ltd (Class A) | David Moreno | President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 270.53 per share. | 01 Jul 2026 | 41,475 | 197,015 (0%) | 0% | 270.5 | 11,220,232 | Ordinary Shares |
| Arteris Inc | K. Charles Janac | Director, President and CEO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 47.08 per share. | 01 Jul 2026 | 40,405 | 8,747,733 | - | 47.1 | 1,902,073 | Common Stock |
| TopBuild Corp | Robert M. Buck | Director, CEO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 01 Jul 2026 | 40,372 | 34,015 (0%) | 0% | 0 | Common Stock | |
| Lixte biotech Holdings Inc | Jason Sawyer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2026 | 40,000 | 65,000 | - | 0 | Common Stock | |
| Oklo Inc (Class A) | Jacob DeWitte | Director, Co-Founder, CEO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 53.28 per share. | 01 Jul 2026 | 40,000 | 569,479 | - | 53.3 | 2,131,200 | Class A Common Stock |
| Oklo Inc (Class A) | Jacob DeWitte | Director, Co-Founder, CEO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 53.71 per share. | 01 Jul 2026 | 40,000 | 536,483 | - | 53.7 | 2,148,400 | Class A Common Stock |
| Oklo Inc (Class A) | Caroline DeWitte | Director, Co-Founder, COO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 53.71 per share. | 01 Jul 2026 | 40,000 | 536,483 | - | 53.7 | 2,148,400 | Class A Common Stock |
| Oklo Inc (Class A) | Caroline DeWitte | Director, Co-Founder, COO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 53.28 per share. | 01 Jul 2026 | 40,000 | 569,479 | - | 53.3 | 2,131,200 | Class A Common Stock |
| Iron Mountain | William L. Meaney | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 37.00 per share. | 01 Jul 2026 | 38,474 | 38,474 (0%) | 0% | 37 | 1,423,538 | Common Stock, par value $.01 per share |
| Iron Mountain | William L. Meaney | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jul 2026 | 38,474 | 192,370 | - | - | Employee Stock Option (Right to Buy) | |
| Xeris Biopharma Holdings Inc | Nerissa C. Kreher | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2026 | 37,910 | 37,910 | - | - | Stock Option (Right to Buy) | |
| Amplify Energy Corp | Todd R. Snyder | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jul 2026 | 36,459 | 164,540 (0%) | 0% | - | Common Stock, par value $0.01 per share | |
| Amplify Energy Corp | Todd R. Snyder | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jul 2026 | 36,459 | 0 | - | - | Restricted Stock Units | |
| Amplify Energy Corp | Deborah G. Adams | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jul 2026 | 36,459 | 0 | - | - | Restricted Stock Units | |
| Amplify Energy Corp | Deborah G. Adams | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jul 2026 | 36,459 | 118,085 (0%) | 0% | - | Common Stock, par value $0.01 per share |
This section tracks all disclosures required by the U.S. Securities and Exchange Commission (SEC) under the Securities Exchange Act of 1934, particularly those related to Section 16 and Rule 10b-5, which govern insider trading activities in the U.S. market. These disclosures are made by corporate insiders, including executives, officers, directors, significant employees, and large shareholders, who are buying and selling stock in their own companies. You can search and filter within these results. You can also sort the information by clicking on the column headers.